Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

Gastric Inhibitory Polypeptide Receptor Antibodies

Close filters
No results were found for the filter!
NEW
Agonist-induced Serine433/Serine435 phosphorylation of GIPR
pS433/pS435-GIPR (phospho-Gastric Inhibitory...
Serine433/Serine435 (S433/S435) is major phosphorylation site of human GIP receptor. The pS433/pS435-GIPR antibody detects phosphorylation in response to agonists. S433/S435 phosphorylation is likely to be involved in efficient ligand...
$ 350.00 *
NEW
pT442/pS443-GIPR (phospho-Gastric Inhibitory Polypeptide Receptor Antibody)
pT442/pS443-GIPR (phospho-Gastric Inhibitory...
Threonine442/Serine443 (T442/S443) is major phosphorylation site of human GIP receptor. The pT442/pS443-GIPR antibody detects phosphorylation in response to agonists. T442/S443 phosphorylation is likely to be involved in efficient ligand...
$ 350.00 *

Gastric inhibitory polypeptide (GIP), also known as glucose-dependent inhibitory polypeptide is synthesised in and secreted from enteroendocrine K-cells in the duodenum and jejunum. Although originally identified as an inhibitor of gastric acid secretion, the best known action of GIP is the potentiation of glucose-dependent insulin secretion via GIP receptors expressed on islet β-cells. The actions of GIP are modulated by the physiological degradation of the peptide via N-terminal cleavage by the aminopeptidase dipeptidyl peptidase IV. GIP receptors preferentially couple through Gs protein to stimulate adenylate cyclase. GIP receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine433/serine435 (pS433/pS435-GIPR) and threonine442/serine443 (pT442/pS443-GIPR). This nomenclature refers to the human GIPR. For more information on GIPR pharmacology please refer to the IUPHAR database. For further reading refer to:

Mayo KE, Miller LJ, Bataille D, Dalle S, Göke B, Thorens B, Drucker DJ. International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev. 2003 Mar;55(1):167-94. doi: 10.1124/pr.55.1.6. PMID: 12615957.

Bataille D, Chan SL, Delagrange P, Drucker DJ, Göke B, Hills R, Mayo KE, Miller LJ, Salvatori R, Thorens B. Glucagon receptor family in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023; 2023(1).

Gastric inhibitory polypeptide (GIP), also known as glucose-dependent inhibitory polypeptide is synthesised in and secreted from enteroendocrine K-cells in the duodenum and jejunum. Although... read more »
Close window
Gastric Inhibitory Polypeptide Receptor Antibodies

Gastric inhibitory polypeptide (GIP), also known as glucose-dependent inhibitory polypeptide is synthesised in and secreted from enteroendocrine K-cells in the duodenum and jejunum. Although originally identified as an inhibitor of gastric acid secretion, the best known action of GIP is the potentiation of glucose-dependent insulin secretion via GIP receptors expressed on islet β-cells. The actions of GIP are modulated by the physiological degradation of the peptide via N-terminal cleavage by the aminopeptidase dipeptidyl peptidase IV. GIP receptors preferentially couple through Gs protein to stimulate adenylate cyclase. GIP receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine433/serine435 (pS433/pS435-GIPR) and threonine442/serine443 (pT442/pS443-GIPR). This nomenclature refers to the human GIPR. For more information on GIPR pharmacology please refer to the IUPHAR database. For further reading refer to:

Mayo KE, Miller LJ, Bataille D, Dalle S, Göke B, Thorens B, Drucker DJ. International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev. 2003 Mar;55(1):167-94. doi: 10.1124/pr.55.1.6. PMID: 12615957.

Bataille D, Chan SL, Delagrange P, Drucker DJ, Göke B, Hills R, Mayo KE, Miller LJ, Salvatori R, Thorens B. Glucagon receptor family in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023; 2023(1).

Recently viewed